Owens & Minor, Inc. (NYSE:OMI) Receives $18.50 Average PT from Brokerages

Owens & Minor, Inc. (NYSE:OMI) has been assigned a consensus recommendation of “Hold” from the eight analysts that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $18.50.

OMI has been the topic of a number of recent analyst reports. Barclays cut their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. UBS Group cut their price target on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Citigroup decreased their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a report on Tuesday, November 5th. Finally, Robert W. Baird cut their target price on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th.

Insider Buying and Selling at Owens & Minor

In related news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now owns 130,822 shares in the company, valued at $1,546,316.04. This represents a 3.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 2.62% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. FMR LLC grew its holdings in shares of Owens & Minor by 0.8% in the 3rd quarter. FMR LLC now owns 11,564,624 shares of the company’s stock worth $181,449,000 after acquiring an additional 90,862 shares during the last quarter. Deerfield Management Company L.P. Series C increased its stake in Owens & Minor by 30.6% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock worth $86,014,000 after purchasing an additional 1,493,852 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Owens & Minor by 1.7% during the second quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company’s stock valued at $61,213,000 after buying an additional 76,599 shares in the last quarter. State Street Corp lifted its stake in Owens & Minor by 2.6% during the third quarter. State Street Corp now owns 3,064,547 shares of the company’s stock valued at $48,083,000 after buying an additional 78,985 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Owens & Minor by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,028,236 shares of the company’s stock worth $31,823,000 after acquiring an additional 187,079 shares in the last quarter. Institutional investors own 98.04% of the company’s stock.

Owens & Minor Price Performance

OMI stock opened at $14.93 on Wednesday. The firm has a market cap of $1.15 billion, a P/E ratio of -22.97, a price-to-earnings-growth ratio of 0.41 and a beta of 0.46. The stock has a 50-day simple moving average of $13.45 and a 200-day simple moving average of $14.25. Owens & Minor has a 1 year low of $11.42 and a 1 year high of $28.35. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The firm had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.44 EPS. On average, equities analysts predict that Owens & Minor will post 1.49 earnings per share for the current fiscal year.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.